Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:6.2.1.7 (
BAL
)
1,977
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We have expressed and purified a truncated recombinant human milk
bile salt-activated lipase
(T-BAL) from the T7 expression system in Escherichia coli. This T-
BAL
contains the N-terminal 538 residues of the 722-residue native enzyme. The purified T-
BAL
, when assayed with PANA (p-nitrophenyl acetate), had a specific activity of 64 +/- 2 units/mg (n = 4), as compared to 52 units/mg for the native enzyme. Because the recombinant T-
BAL
expressed in E. coli is not glycosylated, these results indicated that the highly glycosylated C-terminal region of
BAL
is not essential for catalytic function. Heat inactivation patterns of native
BAL
and T-
BAL
were found to be similar, further suggesting that the folding of T-
BAL
is similar to that of the catalytic domain of the native enzyme. With the availability of a sufficient amount of recombinant T-
BAL
, the specificity and kinetics of T-
BAL
and native
BAL
were compared. Fluorescence studies of T-
BAL
indicated that it has a slightly higher affinity for the monomeric form of taurocholate with a dissociation constant (KA) of 0.32 mM, compared with the reported 0.37 mM for the native enzyme. Further kinetic analysis indicated that there are enzyme specificity changes revealed with the use of PANA and PANB (p-nitrophenyl butyrate) as substrates. When assayed in the presence of taurocholate, T-
BAL
has a higher turnover rate constant with p-nitrophenyl acetate than with p-nitrophenyl butyrate, which was found to be in contrast to native
BAL
.(ABSTRACT TRUNCATED AT 250 WORDS)
...
PMID:Proline-rich domain and glycosylation are not essential for the enzymic activity of bile salt-activated lipase. Kinetic studies of T-BAL, a truncated form of the enzyme, expressed in Escherichia coli. 802 3
An enzyme with lipase and esterase activity was purified from bovine pancreas. Furthermore, a non-radioactive lipase assay was developed which is 100 times more sensitive than the conventional methods and allowed the characterization of the lipase activity of the enzyme. The lipase activity increased 42 times in the presence of 10 mM sodium taurocholate, which for the first time provides direct evidence that a
bile salt-activated lipase
(bp-
BAL
) was isolated from bovine pancreas. This conclusion is further supported by the fact that the N-terminal amino acid sequence of this lipase/esterase is 88% homologous to human milk
BAL
and human pancreatic
BAL
. Staining with various lectins showed that bp-
BAL
is a glycoprotein which contains fucose residues. Previously from bovine pancreas a lysophospholipase has been purified and a gene was cloned and sequenced encoding an enzyme with
cholesterol esterase
/lysophospholipase activity. Comparison of the N-terminal amino acid sequence of bp-
BAL
with the deduced amino acid sequence of the latter revealed that they are identical. Furthermore, the molecular weight of the purified bp-
BAL
of 63,000, as estimated by SDS-PAGE, is very similar to that of the purified lysophospholipase (65,000) and to the theoretical molecular weight of 65,147 of the
cholesterol esterase
/lysophospholipase. These data suggest that these three enzymes are one and the same.
...
PMID:Purification and characterization of bovine pancreatic bile salt-activated lipase. 1022 May 79